Key Takeaways
- • Hedge fund VC activity remains depressed: First-quarter deal volumes among hedge funds with venture capital arms remain far below historical peaks, with Tiger Global—a historic VC leader—making only 15 new private investments in Q1 2025, compared to 289 and 345 investments in 2023 and 2022 respectively.
- • 2022 bear market trauma continues to deter capital: Institutional investors remain cautious following heavy private valuation markdowns during the 2022 stock sell-off, creating persistent hesitation around new private market commitments despite modest activity upticks.
- • Tariff-induced volatility threatens near-term recovery: Current stock market volatility driven by tariff concerns is expected to further suppress venture capital activity and delay the reopening of IPO markets, a critical monetization channel for private investments.
- • Tiger Global's modest rebound signals cautious re-engagement: Tiger Global led the $146 million Series C for Temporal Technologies (valued at $1.72 billion), representing its most active quarter in three years—though still a fraction of historical deployment levels and following Scott Shleifer's departure from the VC unit in late 2023.
- • IPO market closure remains the critical bottleneck: As long as public market volatility persists, IPO markets will remain closed, blocking a major exit and liquidity mechanism for private investments and preventing a broader VC market recovery.
Summary
Hedge funds and their affiliated venture capital arms continue to demonstrate minimal appetite for private market investments, with experts offering little optimism for a near-term revival. According to Crunchbase data, while a handful of historically prominent firms showed slight increases in transaction volume during the first quarter of 2025, deal counts remain dramatically diminished compared to the peak activity of 2022 and 2023. Several major players chose to sit out the quarter entirely, underscoring the sector's continued retrenchment.
Investor psychology remains the primary headwind. Institutional capital remains deeply spooked by the 2022 bear market, when private company valuations were heavily marked down during the broader stock market sell-off. This trauma has created a lasting reluctance among limited partners to commit fresh capital to venture investments, even as early signs of selective re-engagement emerge from a few major players. The current macroeconomic environment offers little relief: tariff-induced volatility in public equity markets is expected to further suppress venture capital deployment and, critically, keep IPO windows sealed. Since IPOs represent a major mechanism for exiting and monetizing private investments, their continued closure creates a structural barrier to recovery.
Tiger Global Management, which operates a dedicated venture capital arm, exemplifies the cautious re-engagement among historically active players. The firm completed at least 15 new private investments in Q1 2025—its highest quarterly tally in nearly three years. However, this modest recovery must be contextualized: Tiger Global deployed 289 and 345 investments in 2023 and 2022 respectively, meaning current activity levels represent only a fraction of historical deployment. Most recently, Tiger Global led a $146 million Series C round for Temporal Technologies, which values the software company at $1.72 billion and grants it unicorn status. Notably, Scott Shleifer, who previously headed Tiger Global's VC effort, stepped back from that role in late 2023, potentially reshaping the firm's private markets strategy going forward.
The absence of a clear catalyst for recovery suggests prolonged caution within hedge fund and institutional investor circles. Until public market volatility subsides and IPO windows reopen, enabling exits from existing private positions, appetite for new venture commitments is likely to remain constrained.
Investor psychology remains the primary headwind. Institutional capital remains deeply spooked by the 2022 bear market, when private company valuations were heavily marked down during the broader stock market sell-off. This trauma has created a lasting reluctance among limited partners to commit fresh capital to venture investments, even as early signs of selective re-engagement emerge from a few major players. The current macroeconomic environment offers little relief: tariff-induced volatility in public equity markets is expected to further suppress venture capital deployment and, critically, keep IPO windows sealed. Since IPOs represent a major mechanism for exiting and monetizing private investments, their continued closure creates a structural barrier to recovery.
Tiger Global Management, which operates a dedicated venture capital arm, exemplifies the cautious re-engagement among historically active players. The firm completed at least 15 new private investments in Q1 2025—its highest quarterly tally in nearly three years. However, this modest recovery must be contextualized: Tiger Global deployed 289 and 345 investments in 2023 and 2022 respectively, meaning current activity levels represent only a fraction of historical deployment. Most recently, Tiger Global led a $146 million Series C round for Temporal Technologies, which values the software company at $1.72 billion and grants it unicorn status. Notably, Scott Shleifer, who previously headed Tiger Global's VC effort, stepped back from that role in late 2023, potentially reshaping the firm's private markets strategy going forward.
The absence of a clear catalyst for recovery suggests prolonged caution within hedge fund and institutional investor circles. Until public market volatility subsides and IPO windows reopen, enabling exits from existing private positions, appetite for new venture commitments is likely to remain constrained.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.